切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 162 -165. doi: 10.3877/cma.j.issn.1674-3946.2020.02.017

所属专题: 文献

论著

早期调节肠道菌群对结肠癌根治术患者的临床意义
卓恩挺1, 王连臣1,(), 陈雪莲1, 符国宏1, 潘建民1   
  1. 1. 572000 海南省第三人民医院普通外科
  • 收稿日期:2019-06-12 出版日期:2020-04-26
  • 通信作者: 王连臣

Clinical significance of early regulation of intestinal flora in patients undergoing radical resection of colon cancer

Enting Zhuo1, Lianchen Wang1,(), Xuelian Chen1, Guohong Fu1, Jianmin Pan1   

  1. 1. General surgery Department, third people’s Hospital of Hainan Province 572000
  • Received:2019-06-12 Published:2020-04-26
  • Corresponding author: Lianchen Wang
  • About author:
    Corresponding author: Wang Lianchen , Email:
  • Supported by:
    Natural science foundation project of hainan province(815205); Haikou science and technology plan fund project(2018JK051)
引用本文:

卓恩挺, 王连臣, 陈雪莲, 符国宏, 潘建民. 早期调节肠道菌群对结肠癌根治术患者的临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(02): 162-165.

Enting Zhuo, Lianchen Wang, Xuelian Chen, Guohong Fu, Jianmin Pan. Clinical significance of early regulation of intestinal flora in patients undergoing radical resection of colon cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(02): 162-165.

目的

探讨早期调节肠道菌群对结肠癌根治术患者早期恢复及应激、免疫功能的影响。

方法

回顾性分析2017年1月至2018年12月于我院胃肠外科行择期结肠癌根治术的85例患者临床资料,将术前2周行肠道菌群调节的患者为干预组(40例),无肠道菌群调节患者为对照组(45例)。采用SPSS24.0进行数据分析及处理。临床指标、肠道菌群数、免疫功能及炎症反应指标等以(±s)描述,组间比较采用独立样本t检验,组内比较采用配对样本t检验,P<0.05表示差异有统计学意义。

结果

干预组术后发热时间短于对照组(P<0.05);干预组患者干预前4种肠道菌群数目与对照组术前1 d相比,差异无统计学意义(P>0.05);干预组患者术前1 d较干预前粪便中双歧杆菌属、乳酸杆菌属数目明显增多(P<0.05),大肠杆菌属及肠球菌属数目明显减少(P<0.05);术后3 d干预组患者双歧杆菌、乳酸杆菌数目明显多于对照组,而大肠杆菌、肠球菌数目明显少于对照组,差异均有统计学意义(P<0.05);术后3 d,干预组患者IL-6及CRP水平均显著优于对照组(P<0.05)。

结论

早期调节肠道菌群能有效改善结肠癌患者术后肠道菌群的紊乱,减轻患者术后机体应激。

Objective

To investigate the effect of early regulation of intestinal flora on early recovery, stress and immune function in patients undergoing radical resection of colon cancer.

Methods

The clinical data of 85 patients underwent elective radical resection of colon cancer in our hospital from January 2017 to December 2018 were retrospectively analyzed. The patients who were given intestinal flora regulation 2 weeks before operation were divided into intervention group (40 cases) and those without intestinal flora regulation were divide into control group (45 cases). SPSS24.0 was used for data analysis. Clinical indicators, number of intestinal flora, immune function and inflammatory response indicators were described by (±s). Independent sample t test was used for inter-group comparison, paired sample t test was used for intra-group comparison, P<0.05 indicated statistically significant difference.

Results

The fever time of intervention group was shorter than that of control group (P<0.05). There was no significant difference in the number of four kinds of intestinal flora in the intervention group compared with that in the control group 1d before the operation (P>0.05); The number of bifidobacteria and lactobacillus in feces in the intervention group was significantly increased (P<0.05), and the number of escherichia coli and enterococci was significantly decreased (P<0.05); The number of bifidobacteria and Lactobacillus in the intervention group was significantly more than that in the control group on the 3rd day after operation, while the number of Escherichia coli and Enterococcus was significantly less than that in the control group (P<0.05). The levels of IL-6 and CRP in the intervention group were significantly lower than those in the control group on the 3rd day after operation (P<0.05).

Conclusion

Early regulation of intestinal flora can effectively improve the intestinal flora disorder after colon cancer surgery and reduce postoperative stress.

表1 85例结肠癌患者是否术前肠道菌群调节两组患者基本资料比较[(±s),例]
图1 结肠癌患者肠道菌群16Sr DNA PCR产物凝胶电泳图[M:标准Marker;1~2:肠球菌PCR产物144 bp,其中1为干预组术前粪便标本,2为对照组术前粪便标本。3~4:双歧杆菌PCR产物234 bp,其中3为干预组术前粪便标本,4为对照组术前粪便标本。5~6:大肠杆菌PCR产物340 bp,其中5为干预组术前粪便标本,6为照组术前粪便标本。7~8:乳酸杆菌PCR产物345 bp,其中7为干预组术前粪便标本,8为照组术前粪便标本。]
表2 85例结肠癌患者是否术前口服益生菌术后两组患者临床恢复指标比较[(±s), d]
表3 85例结肠癌患者是否术前口服益生菌术前术后两组患者肠道菌群数量比较(±s)
表4 85例结肠癌患者是否术前口服益生菌术前术后两组患者IL-6及CRP水平比较(±s)
[1]
徐洪丽,胡俊杰,徐慧婷,等.不同原发部位结肠癌的临床病理及预后分析[J].肿瘤防治研究,2018,45(9):672-675.
[2]
马犇,吴毅,王胜强,等.结肠癌患者肠道菌群分布调查及临床意义分析[J].中国病原生物学杂志,2018,13(7):759-761,765.
[3]
马守宝,刘海燕.肠道菌群在肿瘤进程中的作用及其临床研究进展[J].中国肿瘤生物治疗杂志,2016,23(3):318-325.
[4]
罗东明,黄世锋,徐君毅,等.加速康复外科理念在稳定肠道微生物群中的作用研究进展[J].中华全科医学,2018,16(10):1714-1717.
[5]
郭桂元,黄子成,林婵婵,等.结肠癌根治术后肠道菌群及益生菌干预对结肠癌预后的影响[J].第三军医大学学报,2017,39(23):2293-2298.
[6]
de Andrade Calaca PR,Bezerra RP,Albuquerque WWC,et al. Probiotics as a preventive strategy for surgical infection in colorectal cancer patients:a systematic review and meta-analysis of randomized trials[J].Transl Gastroenterol Hepatol,2017,2:67.
[7]
Motevaseli E,Dianarpour A,Ghafouri-Fard S.The role of probiotics in cancer treatment: Emphasis on their in vivo and in vitro anti-metastatic effects[J].Int J Mol Cell Med,2017,6(2):66-76.
[8]
Bray F, Ferlay J, Soerjomataram I,et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA:A Cancer J Clin,2018,68(6):394-424.
[9]
王宁,刘硕,杨雷,等.2018全球癌症统计报告解读[J/CD].肿瘤综合治疗电子杂志,2019,5(1):87-97.
[10]
卢亚琼,袁文臻,郝建朋,等.肥胖与结直肠癌预后关系的研究进展[J].临床与病理杂志,2017,37(7):1541-1545.
[11]
王生,黄晓星,余鹏飞,等.肠道菌群失调与结肠癌发生发展之间关系的研究进展[J].中国药理学通报,2014,30(8):1045-1048,1049.
[12]
詹宏杰,梁寒.肠道菌群与结直肠癌关系研究进展[J].中国肿瘤临床,2015,42(13):675-679.
[13]
李小伟.双歧三联活菌胶囊对结直肠癌术后炎症反应及肠道微生态的影响[J].中国微生态学杂志,2018,30(1):75-78.
[14]
花蕾,敬兆飞,靳家扬,等.肠道菌群调控炎症微环境在结肠癌中的作用及机制研究进展[J].中国免疫学杂志,2017,33(4):625-629.
[15]
Hartmann P,Chu H,Duan Y,et al.Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either[J].Am J Physio Gastrointest Liver Physiol,2019,316(5):G563-G573.
[16]
Perez-Pardo P,Dodiya HB,Engen PA,et al.Gut bacterial composition in a mouse model of Parkinson’s disease[J].Benef Microbes,2018,9(5):799-814.
[17]
Honda K,Littman DR.The microbiota in adaptive immune homeostasis and disease[J].Nature,2016,535(7610):75-84.
[1] 王振宇, 张洪美, 荆琳, 何名江, 闫奇. 膝骨关节炎相关炎症因子与血浆代谢物间的因果关系及中介效应[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 467-473.
[2] 戴睿, 张亮, 陈浏阳, 张永博, 吴丕根, 孙华, 杨盛, 孟博. 肠道菌群与椎间盘退行性变相关性的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 546-549.
[3] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[4] 李玲, 刘亚, 李培玲, 张秀敏, 李萍. 直肠癌患者术后肠道菌群的变化与抑郁症相关性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 607-610.
[5] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[6] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[7] 高娟, 徐建庆, 闫芳, 丁盛华, 刘霞. Rutkow、TAPP、TEP 手术治疗单侧腹股沟疝患者的临床疗效及对血清炎症因子水平的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 675-680.
[8] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[9] 孙璐, 蒋亚玲, 陈凌君. 布托啡诺对脑缺血再灌注损伤大鼠神经炎症和JAK2/STAT3信号通路的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 344-350.
[10] 蔡艺丹, 方坚, 张志强, 陈莉, 张世安, 夏磊, 阮梅, 李东良. 经颈静脉肝内门体分流术对肝硬化门脉高压患者肠道菌群及肝功能的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 285-293.
[11] 关国欣, 罗福文. 结肠癌合并急性梗阻的个性化处理[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 459-463.
[12] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[13] 杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[14] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[15] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
阅读次数
全文


摘要